Home > Insider Trading > Filing (0001088020-11-000065)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
892160	Derma Sciences Inc.	DSCI	Surgical & Medical Instruments & Apparatus (3841)	232328753

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1058190	F Bruce Wesson	C/O Derma Sciences, Inc. 214 Carnegie Center, Suite 300 Princeton NJ 08540		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-09-06	10,000	$8.08	28,588	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	stock option (right to buy)	Acquisiton	2011-06-24	5,000	$0.00	5,000	$10.26
Common Stock	restricted stock units	Acquisiton	2011-06-24	2,500	$0.00	2,500	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
5,000	2012-05-26	2021-05-26	No	4	A	Direct
2,500	2012-05-26	2012-05-26	No	4	A	Direct

Footnotes

This price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $8.05 to $8.09. The reporting person undertakes to provide Derma Sciences, Inc., any security holder of Derma Sciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Includes 26,088 shares held in an IRA account.
The options were issued in consideration of the reporting person's services to the issuer and without payment of cash consideration, under the issuer's stock option plan.
Upon vesting, the reporting person will receive the number of shares of the issuer's common stock equal to the number of restricted stock units, without payment of further consideration.
The restricted stock units were issued in consideration of the reporting person's services to the issuer and without payment of cash consideration, under the issuer's restricted stock plan.